首页 社会内容详情
telegram群组采集器(www.tel8.vip):Sanofi ends cancer drug trials

telegram群组采集器(www.tel8.vip):Sanofi ends cancer drug trials

分类:社会

网址:

SEO查询: 爱站网 站长工具

点击直达

欧博百家乐网址www.allbet8.vip)是欧博集团的官方网站。欧博百家乐网址开放Allbet注册、Allbe代理、Allbet电脑客户端、Allbet手机版下载等业务。

The decision to stop all studies with amcenestrant follows an analysis of late-stage trial data evaluating the drug in patients with a type of breast cancer, the company said in a statement yesterday.

PARIS: Sanofi is ending development of a key cancer medicine in a blow to the French drugmaker’s pipeline of experimental therapies.

The decision to stop all studies with amcenestrant follows an analysis of late-stage trial data evaluating the drug in patients with a type of breast cancer, the company said in a statement yesterday.

The move leaves Sanofi even more dependent for growth on blockbuster Dupixent, an antibody treatment for ailments ranging from asthma to severe eczema.

The company’s slate of experimental medicines has faced other setbacks, including safety concerns regarding multiple sclerosis treatment tolebrutinib.

,

telegram群组采集器www.tel8.vip)是一个Telegram群组分享平台。telegram群组采集器包括telegram群组采集器、telegram群组索引、Telegram群组导航、新加坡telegram群组、telegram中文群组、telegram群组(其他)、Telegram 美国 群组、telegram群组爬虫、电报群 科学上网、小飞机 怎么 加 群、tg群等内容。telegram群组采集器为广大电报用户提供各种电报群组/电报频道/电报机器人导航服务。

,

Sanofi has included both amcenestrant and tolebrutinib as among six products in its pipeline that it prioritised as “potentially transformative” treatments.

Some investors are questioning the company’s growth trajectory after both of those medicines encountered problems.

UBS analysts last week downgraded Sanofi, saying there are few major catalysts coming soon to drive more excitement to the stock. — Bloomberg


转载说明:本文转载自Sunbet。
  • 蛊咒┖━ @回复Ta

    2022-10-07 00:03:18 

    Another beneficiary of the programme was KR Rathiga, 60, from Kulim, Kedah.这个小站也挺好的

    • 总免不了心伤 @回复Ta

      2022-11-12 04:36:37 

      另外,他提到,新东方财报发布后使得股价有一定程度的提升。“业绩之所以还可以,一方面是经过一年多的调整,新东方业务的大局已经稳定下来,开源节流开始有了初步的成效;另一方面,东方甄选的发展也给新东方带来了机遇和信心。”先码,再看

发布评论